CAMBRIDGE, MA—Syros Pharmaceuticals Inc., which is located in East Cambridge, will relocate to a 52,686-square-foot space in Alewife, Boston Business Journal reported.
Syros, which has been located Kendall Square will relocated to 35 CambridgePark Drive, which is part of The Davis Cos.’s Alewife Research Center, according to Boston Business Journal.
BBJ quoted Syros CEO Nancy Simonian as saying that the company, which currently has 80 employees, is bursting at the seams at the Memorial Drive office.
“We really wanted to look for a place that would accommodate the best interests of our employees,” Simonian told BBJ.
35 CambridgePark Drive is a transit-oriented, five-story facility, and is located next to the Alewife Station, just minutes from both Kendall Square and Harvard Square via the Red Line and readily accessible from the MetroWest suburbs via Route 2.
Syros is pioneering the understanding of the non-coding regulatory region of the genome to advance a new wave of medicines that control the expression of genes. Syros has built a proprietary platform that is designed to systematically and efficiently analyze this unexploited region of DNA to identify and drug novel targets linked to genomically defined patient populations.
